Rigel Pharmaceuticals
RIGL
#6656
Rank
NZ$1.37 B
Marketcap
NZ$73.28
Share price
-2.67%
Change (1 day)
-1.68%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2026 (TTM): NZ$0.15 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.27 Billion. In 2025 the company made an earning of NZ$0.23 Billion, an increase over its 2024 earnings that were of NZ$48.04 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.15 B-32.76%
2025 NZ$0.23 B391.35%
2024 NZ$48.04 M-244.27%
2023 -NZ$33.31 Million-66.79%
2022 -NZ$0.11 Billion340.73%
2021 -NZ$22.76 Million-56.15%
2020 -NZ$51.9 Million-57.34%
2019 -NZ$0.13 Billion-7.66%
2018 -NZ$0.14 Billion-9.47%
2017 -NZ$0.15 Billion24.46%
2016 -NZ$0.12 Billion23.63%
2015 -NZ$94.59 Million-43.29%
2014 -NZ$0.17 Billion2.5%
2013 -NZ$0.17 Billion
2010 NZ$69.2 M-133.97%
2009 -NZ$0.21 Billion-18.49%
2008 -NZ$0.25 Billion71.91%
2007 -NZ$0.15 Billion84.74%
2006 -NZ$78.69 Million-10.17%
2005 -NZ$87.61 Million-15.73%
2004 -NZ$0.11 Billion39.29%
2003 -NZ$74.64 Million10.3%
2002 -NZ$67.67 Million48.3%
2001 -NZ$45.63 Million-2.13%
2000 -NZ$46.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$20.20 B 11,994.42%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$27.58 B 16,412.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-NZ$0.21 Billion-220.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
-NZ$0.24 Billion-242.92%๐Ÿ‡บ๐Ÿ‡ธ USA